Giving the Thrombosis and Hemostasis Community a Voice to Drive Prioritisation
The European Thrombosis and Haemostasis Alliance (ETHA) has 25 member organizations within Europe. If you would like to join this important cause of increasing the share of voice and driving prioritisation of thrombosis and hemostasis in the EU patient safety and cancer research programs, contact us today.
With a united focus on raising awareness of bleeding and clotting disorders, ETHA stands together to work with the public as well as decision makers’ to provide input into EU health and patient safety strategies.
ETHA is led by Prof. Ingrid Pabinger-Fasching, a Professor of Haemostaseology and Vice-Head of the Clinical Division of Haematology and Haemostaseology at the Medical University of Vienna, Austria.